| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.97e-08 | 4 | 40 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 9.66e-06 | 21 | 40 | 3 | GO:0061676 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.56e-04 | 136 | 40 | 4 | GO:0000149 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.34e-04 | 188 | 40 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | syntaxin binding | 7.02e-04 | 87 | 40 | 3 | GO:0019905 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 7.27e-04 | 20 | 40 | 2 | GO:0042800 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 5.40e-06 | 18 | 40 | 3 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 6.41e-06 | 19 | 40 | 3 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 1.16e-05 | 23 | 40 | 3 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 1.33e-05 | 24 | 40 | 3 | GO:0060049 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.57e-05 | 164 | 40 | 5 | GO:0007098 | |
| GeneOntologyBiologicalProcess | Golgi localization | 1.91e-05 | 27 | 40 | 3 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 2.14e-05 | 28 | 40 | 3 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 2.14e-05 | 28 | 40 | 3 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 2.14e-05 | 28 | 40 | 3 | GO:0048313 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.39e-05 | 179 | 40 | 5 | GO:0031023 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 3.88e-05 | 34 | 40 | 3 | GO:0008356 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 4.61e-05 | 36 | 40 | 3 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 5.02e-05 | 37 | 40 | 3 | GO:0000212 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 5.22e-05 | 106 | 40 | 4 | GO:0032091 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 6.35e-05 | 40 | 40 | 3 | GO:1903020 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 1.84e-04 | 57 | 40 | 3 | GO:0007020 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 2.50e-04 | 159 | 40 | 4 | GO:0006888 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 3.09e-04 | 168 | 40 | 4 | GO:0031109 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 3.23e-04 | 170 | 40 | 4 | GO:0051100 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 3.24e-04 | 69 | 40 | 3 | GO:0010559 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 4.47e-04 | 77 | 40 | 3 | GO:0051289 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 5.01e-04 | 80 | 40 | 3 | GO:1903018 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 6.89e-04 | 561 | 40 | 6 | GO:0048568 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 7.53e-04 | 92 | 40 | 3 | GO:0090307 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 9.73e-04 | 228 | 40 | 4 | GO:0043393 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 1.33e-03 | 112 | 40 | 3 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.36e-03 | 113 | 40 | 3 | GO:0051262 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.40e-03 | 114 | 40 | 3 | GO:0050772 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.51e-03 | 117 | 40 | 3 | GO:0046785 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.62e-03 | 906 | 40 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 1.70e-03 | 122 | 40 | 3 | GO:0045132 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.86e-03 | 929 | 40 | 7 | GO:0009792 | |
| GeneOntologyBiologicalProcess | associative learning | 2.04e-03 | 130 | 40 | 3 | GO:0008306 | |
| GeneOntologyCellularComponent | Golgi lumen | 9.90e-13 | 109 | 43 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 4.24e-05 | 33 | 43 | 3 | GO:0000137 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 7.65e-05 | 110 | 43 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.69e-04 | 135 | 43 | 4 | GO:0031985 | |
| GeneOntologyCellularComponent | Golgi stack | 4.16e-04 | 171 | 43 | 4 | GO:0005795 | |
| GeneOntologyCellularComponent | cis-Golgi network | 7.12e-04 | 85 | 43 | 3 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 9.54e-04 | 94 | 43 | 3 | GO:0032580 | |
| GeneOntologyCellularComponent | MLL1 complex | 1.97e-03 | 32 | 43 | 2 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 2.10e-03 | 33 | 43 | 2 | GO:0044665 | |
| HumanPheno | Synophrys | 2.99e-05 | 195 | 11 | 5 | HP:0000664 | |
| HumanPheno | Facial hypertrichosis | 3.90e-05 | 206 | 11 | 5 | HP:0002219 | |
| HumanPheno | Medial flaring of the eyebrow | 6.37e-05 | 228 | 11 | 5 | HP:0010747 | |
| HumanPheno | Hypertrichosis | 1.05e-04 | 425 | 11 | 6 | HP:0000998 | |
| MousePheno | increased alveolar macrophage number | 3.20e-06 | 14 | 30 | 3 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 3.99e-06 | 15 | 30 | 3 | MP:0014227 | |
| MousePheno | abnormal Golgi vesicle transport | 1.34e-05 | 22 | 30 | 3 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 1.75e-05 | 24 | 30 | 3 | MP:0031355 | |
| MousePheno | abnormal alveolar macrophage morphology | 2.52e-05 | 27 | 30 | 3 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 2.82e-05 | 28 | 30 | 3 | MP:0009833 | |
| MousePheno | absent acrosome | 4.24e-05 | 32 | 30 | 3 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 4.66e-05 | 33 | 30 | 3 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 5.10e-05 | 34 | 30 | 3 | MP:0020849 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 1.27e-04 | 46 | 30 | 3 | MP:0020850 | |
| MousePheno | pulmonary fibrosis | 1.73e-04 | 51 | 30 | 3 | MP:0006050 | |
| MousePheno | abnormal surfactant physiology | 2.54e-04 | 58 | 30 | 3 | MP:0004782 | |
| MousePheno | immotile sperm | 2.67e-04 | 59 | 30 | 3 | MP:0020869 | |
| MousePheno | abnormal vesicle-mediated transport | 3.26e-04 | 156 | 30 | 4 | MP:0008546 | |
| MousePheno | abnormal type II pneumocyte morphology | 3.89e-04 | 67 | 30 | 3 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 3.89e-04 | 67 | 30 | 3 | MP:0000880 | |
| MousePheno | abnormal ear morphology | 4.18e-04 | 470 | 30 | 6 | MP:0002102 | |
| MousePheno | abnormal Purkinje cell number | 4.25e-04 | 69 | 30 | 3 | MP:0000878 | |
| MousePheno | abnormal sperm nucleus morphology | 5.22e-04 | 74 | 30 | 3 | MP:0009232 | |
| MousePheno | globozoospermia | 5.22e-04 | 74 | 30 | 3 | MP:0002686 | |
| MousePheno | abnormal cell cytoskeleton morphology | 5.43e-04 | 75 | 30 | 3 | MP:0020378 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 5.86e-04 | 77 | 30 | 3 | MP:0002273 | |
| MousePheno | liver fibrosis | 5.86e-04 | 77 | 30 | 3 | MP:0003333 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 6.56e-04 | 80 | 30 | 3 | MP:0010898 | |
| MousePheno | abnormal Purkinje cell morphology | 8.96e-04 | 204 | 30 | 4 | MP:0000877 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 9.24e-04 | 90 | 30 | 3 | MP:0010901 | |
| MousePheno | abnormal lung morphology | 9.77e-04 | 767 | 30 | 7 | MP:0001175 | |
| MousePheno | abnormal acrosome assembly | 9.85e-04 | 92 | 30 | 3 | MP:0031354 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 1.08e-03 | 95 | 30 | 3 | MP:0009832 | |
| MousePheno | abnormal respiratory system morphology | 1.12e-03 | 1027 | 30 | 8 | MP:0002132 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 1.19e-03 | 220 | 30 | 4 | MP:0000875 | |
| MousePheno | rough coat | 1.19e-03 | 24 | 30 | 2 | MP:0010179 | |
| MousePheno | decreased sperm progressive motility | 1.25e-03 | 100 | 30 | 3 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 1.29e-03 | 101 | 30 | 3 | MP:0020450 | |
| Domain | SEA | 1.47e-09 | 23 | 42 | 5 | PS50024 | |
| Domain | SEA_dom | 1.47e-09 | 23 | 42 | 5 | IPR000082 | |
| Domain | SEA | 2.17e-08 | 14 | 42 | 4 | SM00200 | |
| Domain | VWFD | 3.94e-08 | 16 | 42 | 4 | PS51233 | |
| Domain | VWD | 3.94e-08 | 16 | 42 | 4 | SM00216 | |
| Domain | VWF_type-D | 3.94e-08 | 16 | 42 | 4 | IPR001846 | |
| Domain | VWD | 3.94e-08 | 16 | 42 | 4 | PF00094 | |
| Domain | SEA | 1.57e-07 | 22 | 42 | 4 | PF01390 | |
| Domain | TIL | 2.29e-06 | 12 | 42 | 3 | PF01826 | |
| Domain | C8 | 2.29e-06 | 12 | 42 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.98e-06 | 13 | 42 | 3 | IPR014853 | |
| Domain | C8 | 2.98e-06 | 13 | 42 | 3 | SM00832 | |
| Domain | TIL_dom | 3.78e-06 | 14 | 42 | 3 | IPR002919 | |
| Domain | CTCK_1 | 8.43e-06 | 18 | 42 | 3 | PS01185 | |
| Domain | GOLGA2L5 | 8.43e-06 | 18 | 42 | 3 | PF15070 | |
| Domain | Golgin_A | 8.43e-06 | 18 | 42 | 3 | IPR024858 | |
| Domain | VWC_out | 9.99e-06 | 19 | 42 | 3 | SM00215 | |
| Domain | CT | 1.58e-05 | 22 | 42 | 3 | SM00041 | |
| Domain | Cys_knot_C | 2.35e-05 | 25 | 42 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.35e-05 | 25 | 42 | 3 | PS01225 | |
| Domain | WxxW_domain | 7.36e-05 | 6 | 42 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 7.36e-05 | 6 | 42 | 2 | PF13330 | |
| Domain | VWC | 8.44e-05 | 38 | 42 | 3 | SM00214 | |
| Domain | VWFC_2 | 8.44e-05 | 38 | 42 | 3 | PS50184 | |
| Domain | VWF_dom | 1.14e-04 | 42 | 42 | 3 | IPR001007 | |
| Domain | EGF_1 | 2.57e-04 | 255 | 42 | 5 | PS00022 | |
| Domain | EGF-like_CS | 2.86e-04 | 261 | 42 | 5 | IPR013032 | |
| Domain | EGF_2 | 3.07e-04 | 265 | 42 | 5 | PS01186 | |
| Domain | Znf_FYVE_PHD | 3.27e-04 | 147 | 42 | 4 | IPR011011 | |
| Domain | Glyco_hormone_CN | 5.09e-04 | 15 | 42 | 2 | IPR006208 | |
| Domain | Cys_knot | 5.09e-04 | 15 | 42 | 2 | PF00007 | |
| Domain | - | 5.09e-04 | 15 | 42 | 2 | 3.30.70.960 | |
| Domain | Post-SET_dom | 5.81e-04 | 16 | 42 | 2 | IPR003616 | |
| Domain | PostSET | 5.81e-04 | 16 | 42 | 2 | SM00508 | |
| Domain | POST_SET | 5.81e-04 | 16 | 42 | 2 | PS50868 | |
| Domain | PHD | 6.38e-04 | 75 | 42 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 7.42e-04 | 79 | 42 | 3 | IPR019787 | |
| Domain | PHD | 1.05e-03 | 89 | 42 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.12e-03 | 91 | 42 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.27e-03 | 95 | 42 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.31e-03 | 96 | 42 | 3 | PS01359 | |
| Domain | VWC | 1.80e-03 | 28 | 42 | 2 | PF00093 | |
| Domain | EGF_3 | 1.88e-03 | 235 | 42 | 4 | PS50026 | |
| Domain | EGF | 1.88e-03 | 235 | 42 | 4 | SM00181 | |
| Domain | EGF-like_dom | 2.32e-03 | 249 | 42 | 4 | IPR000742 | |
| Domain | VWFC_1 | 2.96e-03 | 36 | 42 | 2 | PS01208 | |
| Domain | BROMODOMAIN_2 | 3.83e-03 | 41 | 42 | 2 | PS50014 | |
| Domain | SET | 3.83e-03 | 41 | 42 | 2 | PF00856 | |
| Domain | BROMO | 4.02e-03 | 42 | 42 | 2 | SM00297 | |
| Domain | Bromodomain | 4.02e-03 | 42 | 42 | 2 | IPR001487 | |
| Domain | - | 4.02e-03 | 42 | 42 | 2 | 1.20.920.10 | |
| Domain | SET | 4.80e-03 | 46 | 42 | 2 | SM00317 | |
| Domain | SET_dom | 5.65e-03 | 50 | 42 | 2 | IPR001214 | |
| Domain | SET | 5.65e-03 | 50 | 42 | 2 | PS50280 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.05e-15 | 16 | 30 | 7 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.78e-15 | 17 | 30 | 7 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.23e-14 | 23 | 30 | 7 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.95e-14 | 26 | 30 | 7 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.03e-12 | 68 | 30 | 8 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.90e-12 | 21 | 30 | 6 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.22e-11 | 62 | 30 | 7 | M546 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.80e-11 | 111 | 30 | 8 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.46e-10 | 143 | 30 | 8 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.39e-09 | 109 | 30 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.52e-09 | 60 | 30 | 6 | MM15636 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.38e-08 | 140 | 30 | 7 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.65e-08 | 250 | 30 | 8 | M27554 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | GOLGA6C ADAMTS12 GOLGA6D MUC19 MUC16 GOLGA6B MUC5B MUC17 MUC4 MUC5AC SEC24B USP24 | 1.28e-05 | 1389 | 30 | 12 | MM15307 |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 1.50e-05 | 23 | 30 | 3 | MM14620 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 2.72e-05 | 83 | 30 | 4 | MM14819 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 3.32e-04 | 64 | 30 | 3 | MM15601 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 4.19e-04 | 168 | 30 | 4 | MM14785 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 MUC16 MUC5B MUC12 MUC17 MUC3A MUC4 MUC5AC SEC24B USP24 | 6.42e-04 | 1475 | 30 | 10 | M19806 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 8.38e-04 | 202 | 30 | 4 | MM15650 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.38e-03 | 26 | 30 | 2 | M47439 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.61e-03 | 110 | 30 | 3 | MM15350 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.78e-03 | 114 | 30 | 3 | MM15361 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 3.27e-03 | 293 | 30 | 4 | MM15120 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 4.28e-03 | 46 | 30 | 2 | MM14933 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.45e-19 | 18 | 44 | 8 | 18834073 | |
| Pubmed | 3.33e-11 | 6 | 44 | 4 | 19110483 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2A NCOA3 BPTF AFF1 DEAF1 TAF6 UBN1 PAPOLA PRRC2A ZMYM4 CCNL1 USP24 | 1.49e-10 | 774 | 44 | 12 | 15302935 |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.89e-09 | 3 | 44 | 3 | 18163520 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 10512748 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.89e-08 | 5 | 44 | 3 | 11062147 | |
| Pubmed | 1.27e-07 | 36 | 44 | 4 | 30026494 | ||
| Pubmed | 3.94e-07 | 549 | 44 | 8 | 38280479 | ||
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 5.36e-07 | 13 | 44 | 3 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 5.36e-07 | 13 | 44 | 3 | 32873390 | |
| Pubmed | 5.36e-07 | 13 | 44 | 3 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 5.36e-07 | 13 | 44 | 3 | 29128360 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 5.36e-07 | 13 | 44 | 3 | 28055014 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 5.36e-07 | 13 | 44 | 3 | 28028212 | |
| Pubmed | 6.81e-07 | 14 | 44 | 3 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 6.81e-07 | 14 | 44 | 3 | 27226319 | |
| Pubmed | 6.81e-07 | 14 | 44 | 3 | 37831422 | ||
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 6.81e-07 | 14 | 44 | 3 | 33543287 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 8.48e-07 | 608 | 44 | 8 | 36089195 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 8.50e-07 | 15 | 44 | 3 | 17046993 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 8.50e-07 | 15 | 44 | 3 | 26165940 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 8.50e-07 | 15 | 44 | 3 | 17189423 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 8.50e-07 | 15 | 44 | 3 | 17204322 | |
| Pubmed | 8.50e-07 | 15 | 44 | 3 | 26083584 | ||
| Pubmed | 8.50e-07 | 15 | 44 | 3 | 16413118 | ||
| Pubmed | 8.50e-07 | 15 | 44 | 3 | 37635409 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 8.50e-07 | 15 | 44 | 3 | 23185636 | |
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 8.50e-07 | 15 | 44 | 3 | 28509431 | |
| Pubmed | 1.05e-06 | 16 | 44 | 3 | 16399995 | ||
| Pubmed | 1.05e-06 | 16 | 44 | 3 | 16336229 | ||
| Pubmed | 1.05e-06 | 16 | 44 | 3 | 18166528 | ||
| Pubmed | 1.05e-06 | 16 | 44 | 3 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 1.05e-06 | 16 | 44 | 3 | 21640725 | |
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 1.27e-06 | 17 | 44 | 3 | 14718562 | |
| Pubmed | 1.27e-06 | 17 | 44 | 3 | 27655914 | ||
| Pubmed | 1.27e-06 | 17 | 44 | 3 | 14728599 | ||
| Pubmed | 1.27e-06 | 17 | 44 | 3 | 28717168 | ||
| Pubmed | 1.27e-06 | 17 | 44 | 3 | 20004763 | ||
| Pubmed | 1.52e-06 | 18 | 44 | 3 | 21147753 | ||
| Pubmed | 1.52e-06 | 18 | 44 | 3 | 15800058 | ||
| Pubmed | 1.52e-06 | 18 | 44 | 3 | 24227724 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 1.52e-06 | 18 | 44 | 3 | 20230794 | |
| Pubmed | 1.52e-06 | 18 | 44 | 3 | 22718342 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 1.52e-06 | 18 | 44 | 3 | 24367100 | |
| Pubmed | 1.52e-06 | 18 | 44 | 3 | 20943658 | ||
| Pubmed | 1.52e-06 | 18 | 44 | 3 | 25208654 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 7513696 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.56e-06 | 2 | 44 | 2 | 23272068 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.56e-06 | 2 | 44 | 2 | 27729120 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 28646023 | ||
| Pubmed | Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. | 1.56e-06 | 2 | 44 | 2 | 9326653 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 9334251 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 34058148 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 37146737 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.56e-06 | 2 | 44 | 2 | 23527003 | |
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.56e-06 | 2 | 44 | 2 | 14988081 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 16540890 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15563276 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 36111525 | ||
| Pubmed | Establishment of MLL/AF4 transgenic mice with the phenotype of lymphoblastic leukemia or lymphoma. | 1.56e-06 | 2 | 44 | 2 | 24189350 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 18782111 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 16169901 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 12958310 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 1.56e-06 | 2 | 44 | 2 | 18475301 | |
| Pubmed | Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. | 1.56e-06 | 2 | 44 | 2 | 7689231 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22220206 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 24317696 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.56e-06 | 2 | 44 | 2 | 27845589 | |
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 1.56e-06 | 2 | 44 | 2 | 2393399 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 11289722 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22391959 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.56e-06 | 2 | 44 | 2 | 35776514 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 11930009 | ||
| Pubmed | H3K79 methylation profiles define murine and human MLL-AF4 leukemias. | 1.56e-06 | 2 | 44 | 2 | 18977325 | |
| Pubmed | Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein. | 1.56e-06 | 2 | 44 | 2 | 14990976 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 27435107 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23544943 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 24327612 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 26871672 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 34575904 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.56e-06 | 2 | 44 | 2 | 21653907 | |
| Pubmed | MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. | 1.56e-06 | 2 | 44 | 2 | 27856324 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.56e-06 | 2 | 44 | 2 | 36427316 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 34489550 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 16551973 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 14690056 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.56e-06 | 2 | 44 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.56e-06 | 2 | 44 | 2 | 11587997 | |
| Pubmed | Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia. | 1.56e-06 | 2 | 44 | 2 | 17889710 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.56e-06 | 2 | 44 | 2 | 28607090 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 1423625 | ||
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 1.56e-06 | 2 | 44 | 2 | 19158956 | |
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 1.56e-06 | 2 | 44 | 2 | 10973822 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 38029383 | ||
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 1.56e-06 | 2 | 44 | 2 | 24722639 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.56e-06 | 2 | 44 | 2 | 24332705 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 21135858 | ||
| Interaction | CLRN3 interactions | 2.20e-06 | 13 | 41 | 3 | int:CLRN3 | |
| Interaction | HNF4A interactions | 1.84e-05 | 275 | 41 | 6 | int:HNF4A | |
| Interaction | H3-4 interactions | 2.99e-05 | 448 | 41 | 7 | int:H3-4 | |
| Interaction | KLF8 interactions | 5.02e-05 | 329 | 41 | 6 | int:KLF8 | |
| Interaction | H3-3A interactions | 1.13e-04 | 749 | 41 | 8 | int:H3-3A | |
| Interaction | ELF1 interactions | 1.23e-04 | 126 | 41 | 4 | int:ELF1 | |
| Interaction | SMC5 interactions | 1.46e-04 | 1000 | 41 | 9 | int:SMC5 | |
| Cytoband | 7q22 | 6.77e-06 | 38 | 44 | 3 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 5.89e-05 | 219 | 44 | 4 | chr7q22 | |
| Cytoband | 11p15.5 | 2.03e-04 | 118 | 44 | 3 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 2.24e-04 | 122 | 44 | 3 | chr15q24 | |
| Cytoband | 15q24.2 | 4.37e-04 | 32 | 44 | 2 | 15q24.2 | |
| Cytoband | 7q22.1 | 5.31e-03 | 113 | 44 | 2 | 7q22.1 | |
| GeneFamily | CD molecules|Mucins | 1.02e-23 | 21 | 30 | 10 | 648 | |
| GeneFamily | PHD finger proteins | 4.39e-04 | 90 | 30 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.44e-03 | 34 | 30 | 2 | 487 | |
| Coexpression | NABA_ECM_AFFILIATED | 7.66e-12 | 170 | 43 | 9 | M5880 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 MUC19 MUC16 MUC5B MUC12 ITIH6 MUC22 MUC17 MUC3A MUC4 MUC5AC | 2.48e-08 | 751 | 43 | 11 | M5885 |
| Coexpression | NABA_ECM_AFFILIATED | 2.21e-07 | 158 | 43 | 6 | MM17063 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 MUC19 MUC16 MUC5B MUC12 ITIH6 MUC22 MUC17 MUC3A MUC4 MUC5AC | 5.70e-07 | 1026 | 43 | 11 | M5889 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 9.95e-06 | 466 | 43 | 7 | M13522 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.59e-05 | 856 | 43 | 8 | M4500 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.28e-04 | 300 | 43 | 5 | M8702 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.82e-04 | 738 | 43 | 7 | MM17058 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.00e-10 | 179 | 43 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-10 | 180 | 43 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-10 | 180 | 43 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 4.85e-10 | 184 | 43 | 7 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.24e-08 | 183 | 43 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-08 | 199 | 43 | 6 | eb2d1b7e875c5bf833e7a80b43282e12893c34e9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.80e-08 | 200 | 43 | 6 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.47e-07 | 159 | 43 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.19e-07 | 184 | 43 | 5 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 190 | 43 | 5 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 190 | 43 | 5 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-06 | 195 | 43 | 5 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 1.25e-06 | 196 | 43 | 5 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-06 | 199 | 43 | 5 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-06 | 199 | 43 | 5 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.35e-06 | 199 | 43 | 5 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.39e-06 | 200 | 43 | 5 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-06 | 200 | 43 | 5 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-06 | 200 | 43 | 5 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 164 | 43 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 168 | 43 | 4 | 4a2e08b047f7170ae4b95eac9b2b128e55beee4a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 168 | 43 | 4 | 3e09516e819cf140a6dbf8f85247d3f08aa35bb8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 171 | 43 | 4 | 0417fa805ca0acb7e9f6a30bc7b6bdbaba77844d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-05 | 173 | 43 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-05 | 175 | 43 | 4 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-05 | 175 | 43 | 4 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.48e-05 | 176 | 43 | 4 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-05 | 177 | 43 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-05 | 177 | 43 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.59e-05 | 178 | 43 | 4 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.59e-05 | 178 | 43 | 4 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.59e-05 | 178 | 43 | 4 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 178 | 43 | 4 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 178 | 43 | 4 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 179 | 43 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.71e-05 | 180 | 43 | 4 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.71e-05 | 180 | 43 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.83e-05 | 182 | 43 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 2.89e-05 | 183 | 43 | 4 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 184 | 43 | 4 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-05 | 185 | 43 | 4 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-05 | 186 | 43 | 4 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 188 | 43 | 4 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-05 | 188 | 43 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-05 | 188 | 43 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-05 | 188 | 43 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.27e-05 | 189 | 43 | 4 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-05 | 190 | 43 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.34e-05 | 190 | 43 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-05 | 190 | 43 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-05 | 191 | 43 | 4 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 192 | 43 | 4 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 192 | 43 | 4 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 3.48e-05 | 192 | 43 | 4 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-05 | 193 | 43 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-05 | 193 | 43 | 4 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-05 | 193 | 43 | 4 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.55e-05 | 193 | 43 | 4 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-05 | 193 | 43 | 4 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-05 | 193 | 43 | 4 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.63e-05 | 194 | 43 | 4 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-05 | 194 | 43 | 4 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.70e-05 | 195 | 43 | 4 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.70e-05 | 195 | 43 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-05 | 195 | 43 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.70e-05 | 195 | 43 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 3.70e-05 | 195 | 43 | 4 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-05 | 196 | 43 | 4 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-05 | 196 | 43 | 4 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.77e-05 | 196 | 43 | 4 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.77e-05 | 196 | 43 | 4 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.77e-05 | 196 | 43 | 4 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.77e-05 | 196 | 43 | 4 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 3.77e-05 | 196 | 43 | 4 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-05 | 196 | 43 | 4 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-05 | 196 | 43 | 4 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-05 | 196 | 43 | 4 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.77e-05 | 196 | 43 | 4 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-05 | 196 | 43 | 4 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 197 | 43 | 4 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-05 | 197 | 43 | 4 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.85e-05 | 197 | 43 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-05 | 197 | 43 | 4 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.85e-05 | 197 | 43 | 4 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-05 | 197 | 43 | 4 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.93e-05 | 198 | 43 | 4 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 198 | 43 | 4 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 198 | 43 | 4 | 9c5d7852f03468394e726c444cac92a043fc6d0e | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.93e-05 | 198 | 43 | 4 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.93e-05 | 198 | 43 | 4 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.93e-05 | 198 | 43 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 198 | 43 | 4 | f95f38cc747fb3549a791288bf8d0518c049ac96 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 198 | 43 | 4 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | distal-Epithelial-Mucous-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 35fb7bd35e53d8ca189fe8c7744211a5201081f6 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Club|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.00e-05 | 199 | 43 | 4 | 111cfd589ec6795075d8d88d7664bfb23eba5bf6 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.00e-05 | 199 | 43 | 4 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 199 | 43 | 4 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 199 | 43 | 4 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 4.00e-05 | 199 | 43 | 4 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 199 | 43 | 4 | f37114cf849837fdb8ed9a767de773e8681b7df3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 21 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Neighborhood of DDX5 | 2.37e-04 | 63 | 21 | 3 | GNF2_DDX5 | |
| Drug | cellobiitol | 4.73e-09 | 37 | 39 | 5 | CID000003871 | |
| Drug | rioprostil | 2.55e-07 | 32 | 39 | 4 | CID005311413 | |
| Drug | Gastrin tetrapeptide | 1.60e-06 | 50 | 39 | 4 | CID000005415 | |
| Drug | guanidine hydrochloride | 2.66e-06 | 129 | 39 | 5 | CID000005742 | |
| Drug | inulin | 3.10e-06 | 133 | 39 | 5 | CID000024763 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.06e-05 | 171 | 39 | 5 | 7535_DN | |
| Drug | mucic acid | 1.55e-05 | 88 | 39 | 4 | CID000000607 | |
| Drug | I pN | 5.47e-05 | 43 | 39 | 3 | CID000012276 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.89e-08 | 64 | 41 | 5 | DOID:4947 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.58e-06 | 61 | 41 | 4 | DOID:3587 (is_marker_for) | |
| Disease | Sjogren's syndrome (is_marker_for) | 4.94e-06 | 24 | 41 | 3 | DOID:12894 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 5.65e-06 | 3 | 41 | 2 | DOID:9368 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.88e-05 | 5 | 41 | 2 | DOID:3030 (is_marker_for) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 3.94e-05 | 7 | 41 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 5.25e-05 | 8 | 41 | 2 | DOID:4608 (is_marker_for) | |
| Disease | dry eye syndrome (is_marker_for) | 8.42e-05 | 10 | 41 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 8.42e-05 | 10 | 41 | 2 | DOID:10754 (is_marker_for) | |
| Disease | pulmonary fibrosis | 1.03e-04 | 11 | 41 | 2 | EFO_0009448 | |
| Disease | otitis media (biomarker_via_orthology) | 2.53e-04 | 17 | 41 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | pancreatic cancer (is_marker_for) | 3.78e-04 | 101 | 41 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Precursor B-cell lymphoblastic leukemia | 3.89e-04 | 21 | 41 | 2 | C1292769 | |
| Disease | Cerebral Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0334583 | |
| Disease | Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 5.54e-04 | 25 | 41 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 5.54e-04 | 25 | 41 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 5.99e-04 | 26 | 41 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 5.99e-04 | 26 | 41 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 5.99e-04 | 26 | 41 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 6.47e-04 | 27 | 41 | 2 | C0334579 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 8.54e-04 | 31 | 41 | 2 | C1335167 | |
| Disease | COVID-19 symptoms measurement | 1.09e-03 | 35 | 41 | 2 | EFO_0600019 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.15e-03 | 148 | 41 | 3 | C0279702 | |
| Disease | Takayasu arteritis | 1.15e-03 | 148 | 41 | 3 | EFO_1001857 | |
| Disease | Burkitt Lymphoma | 1.15e-03 | 36 | 41 | 2 | C0006413 | |
| Disease | heart rate response to exercise | 1.64e-03 | 43 | 41 | 2 | EFO_0009184 | |
| Disease | plasminogen activator inhibitor 1 measurement | 2.58e-03 | 54 | 41 | 2 | EFO_0004792 | |
| Disease | Small cell carcinoma of lung | 2.58e-03 | 54 | 41 | 2 | C0149925 | |
| Disease | leukemia | 2.67e-03 | 55 | 41 | 2 | C0023418 | |
| Disease | metabolic syndrome | 2.71e-03 | 200 | 41 | 3 | EFO_0000195 | |
| Disease | triglycerides in LDL measurement | 2.77e-03 | 56 | 41 | 2 | EFO_0022320 | |
| Disease | idiopathic pulmonary fibrosis | 2.86e-03 | 57 | 41 | 2 | EFO_0000768 | |
| Disease | fatty acid measurement | 3.09e-03 | 436 | 41 | 4 | EFO_0005110 | |
| Disease | triglycerides in small VLDL measurement | 3.27e-03 | 61 | 41 | 2 | EFO_0022145 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 3.36e-03 | 216 | 41 | 3 | EFO_0007925, EFO_0007927 | |
| Disease | triglycerides in medium LDL measurement | 3.38e-03 | 62 | 41 | 2 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.38e-03 | 62 | 41 | 2 | EFO_0022339 | |
| Disease | triglycerides in small HDL measurement | 3.38e-03 | 62 | 41 | 2 | EFO_0022158 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TDGTAGTPAISTTTT | 146 | Q9H6B1 | |
| SSGTTTTTTTTTGGI | 26 | Q9UK58 | |
| TTVTKLSTPSTGGSV | 1756 | Q12830 | |
| TGPTSEGGLVATTTS | 1111 | P58397 | |
| TATTTGATGSVATPS | 2026 | Q9HC84 | |
| TTSGSTVTPSSIPGT | 4631 | Q9HC84 | |
| TEVSTTSTGAATGGP | 881 | Q9HCM3 | |
| ESSGVTITTQTGPTG | 4381 | Q8WXI7 | |
| STPGTSTVDVGTSGT | 12201 | Q8WXI7 | |
| STPGTSTVDLGTSGT | 12826 | Q8WXI7 | |
| TSTPGTSTVDLGTSG | 12981 | Q8WXI7 | |
| TGSKTAAPVTSTGST | 36 | Q99102 | |
| VTTSTGSTLGNPGET | 266 | Q99102 | |
| TKTVTTPGSSFTASG | 661 | Q99102 | |
| SGTTPSGSEGISTSG | 811 | Q99102 | |
| SPTGSQTTIVSISGS | 301 | E2RYF6 | |
| TGSGTASPVEGTSAV | 21 | Q5VZ46 | |
| GTTESSAGVTGTRPS | 2696 | Q7Z5P9 | |
| TTGPSAGVTVTSGQS | 2876 | Q7Z5P9 | |
| TTSPSVRGTETTGQS | 3126 | Q7Z5P9 | |
| TTGTPAGVTGTTELS | 3406 | Q7Z5P9 | |
| TTGPSAGVTETTGSS | 3506 | Q7Z5P9 | |
| TTGLSTEVTGTTGPS | 3546 | Q7Z5P9 | |
| SGLSAEVTGTTGPSA | 3716 | Q7Z5P9 | |
| TGPSAGVTGTTTVSA | 3796 | Q7Z5P9 | |
| VTGTTGSSTGVTGIT | 4041 | Q7Z5P9 | |
| VTGTTGPSAGVTRTT | 4071 | Q7Z5P9 | |
| TGTTEPSAGLTETTG | 4341 | Q7Z5P9 | |
| PSAGLTETTGSSTGV | 4346 | Q7Z5P9 | |
| TGTTGISTEVTGTTG | 4371 | Q7Z5P9 | |
| TGTTGPSARVTGTTV | 4381 | Q7Z5P9 | |
| GTSTPSVGETGTTRT | 4421 | Q7Z5P9 | |
| SAEATGTTGPSAGVT | 4656 | Q7Z5P9 | |
| SAEATGTTGPSAGVT | 5256 | Q7Z5P9 | |
| ETTGPSAEVTGTTGS | 5461 | Q7Z5P9 | |
| SAGVTGTTGPSAEAT | 5486 | Q7Z5P9 | |
| IAPGSTTTGTTGVTT | 6151 | Q7Z5P9 | |
| AATTSPGASGTTGVT | 6971 | Q7Z5P9 | |
| PGASGTTGVTTTTKT | 6976 | Q7Z5P9 | |
| TTSPGASGMTGVTTT | 7091 | Q7Z5P9 | |
| GTSGVSLATTVAPGS | 7236 | Q7Z5P9 | |
| TAATTSPGASGVTGT | 7701 | Q7Z5P9 | |
| SSSQTVIPGSSGTIS | 7796 | Q7Z5P9 | |
| PGSSVTGTTTGASDD | 7816 | Q7Z5P9 | |
| GVALSTTVAPGSSST | 7841 | Q7Z5P9 | |
| TPGSTGVTSSQEGTT | 8051 | Q7Z5P9 | |
| TTVATTGTGQTTFPS | 1341 | Q02505 | |
| SISPNASSSTGTGTV | 2841 | Q02505 | |
| ASSSTGTGTVPTNTV | 2846 | Q02505 | |
| TTSAPTTSTTSGPGT | 2436 | P98088 | |
| TTSTTSGAGTTPSPV | 2521 | P98088 | |
| TSAPTTSTTSGPGTT | 2581 | P98088 | |
| SASTTSTTSGPGTTP | 2646 | P98088 | |
| SASTTSTTSGPGTTP | 2686 | P98088 | |
| TSAPTTSTTSGPGTT | 2821 | P98088 | |
| TATTSTTSGPGTTPS | 2871 | P98088 | |
| SASTTSTTSGPGTTP | 2966 | P98088 | |
| STTSASTTSTTPGPG | 3171 | P98088 | |
| SSTTSGSGTTPSPVT | 3476 | P98088 | |
| GSGTTPSPVTTTSTA | 3481 | P98088 | |
| TTSAPTTSTTSGPGT | 4241 | P98088 | |
| TSAPTTSTTSGPGTT | 4306 | P98088 | |
| STTSAPTTSTTSGPG | 4576 | P98088 | |
| TVGSTTVGPTTVGST | 5116 | P98088 | |
| TDSSPETTTSGGGHS | 51 | A6NDN3 | |
| SSGGTSSESIPQTAT | 586 | P51003 | |
| TTFTVTPSGQITTSG | 331 | O75398 | |
| TDSSPETTTSGGGHS | 51 | A6NDK9 | |
| STGPSSTTTTSVLGE | 911 | Q6UXX5 | |
| TDSSPETTTSGGGHS | 51 | P0CG33 | |
| STQTTGITAASPSGE | 3431 | Q03164 | |
| DQETTSLTSGTGTPG | 3571 | Q03164 | |
| SPVVSTVLSGSSGSS | 311 | O95487 | |
| TVGTLSETSTGGPAT | 636 | Q9P1Z2 | |
| VSPGGTVTLTCGSST | 31 | A0A075B6I9 | |
| GTSIAISTPSEGSTA | 1501 | Q685J3 | |
| TTSTEGSSSPTTAEG | 2901 | Q685J3 | |
| TTASEGSSSPTTLEG | 3786 | Q685J3 | |
| SSSTGTGTVPTNTVF | 761 | Q9H195 | |
| SGTPSIAVSGTSLSS | 306 | Q8TDW5 | |
| PGSGSTTTSPVTTTV | 561 | P49848 | |
| SASSASPTVDGTTTG | 296 | Q8IV36 | |
| QGGSTGTSPTTSSTG | 341 | Q96SF7 | |
| VSVTSPSGVSSSTSG | 651 | Q9Y6Q9 | |
| PSGVSSSTSGGVSST | 656 | Q9Y6Q9 | |
| APTLVSGGGSTSSTS | 566 | P48634 | |
| TPTSPTVSVTGAGTD | 1781 | Q9Y566 | |
| GSVGSSGVAATISTP | 1121 | P51825 | |
| GSTSTGHVTSLPSSG | 861 | Q01973 | |
| STPTGGSDTLVGTSL | 156 | Q15772 | |
| GNDGSLTTTTTSTTP | 301 | Q6IQ55 | |
| PGETTSTSSASGVSG | 236 | C9JH25 | |
| TQSVSSPEATSGSTG | 556 | Q9BZ95 | |
| TVKTSGSGTPSGSSA | 1031 | Q9UPU5 | |
| GSSSSGGTPVQSSVS | 916 | Q9NPG3 | |
| AGTGTGTSTPSTPTT | 136 | Q5T0B9 | |
| STVSAGGGSTSAVSP | 641 | Q5VZL5 | |
| GGGSTSAVSPTSISS | 646 | Q5VZL5 | |
| TTAATGTGQGPSTST | 1051 | O95071 | |
| GSTETTALPGSTTTA | 1671 | Q9UKN1 | |
| GSTETTALPGSTTTA | 4311 | Q9UKN1 |